
Please try another search
Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Mikael von Euler | 70 | - | Independent Director |
Eva Sjokvist Saers | 61 | 2020 | Independent Chairman of the Board |
Per-Goran Gillberg | - | 2021 | Independent Director |
Fredrik Buch | 71 | 2022 | Independent Director |
Jan-Eric Österlund | 80 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review